Personal information

Emails & domains

Verified email domains

Websites & social links

http://www.iquibicen.fcen.uba.ar/research/laboratorio-de-inflamacion-y-cancer/

Other IDs

Scopus Author ID: 16066560000
SciProfiles: 630434

Keywords

Prostate cancer, Acute lymphoblastic leukemia, Molecular biology, Genetics, Biomarker discovery

Countries

Argentina

Activities

Collapse all

Employment (2)

IQUIBICEN, CONICET: Buenos Aires, AR

2010 to present
Employment
Source: Self-asserted source
Javier Cotignola

Universidad de Buenos Aires Facultad de Ciencias Exactas y Naturales: Buenos Aires, AR

2007 to present
Employment
Source: Self-asserted source
Javier Cotignola

Education and qualifications (2)

Universidad de Buenos Aires: CABA, AR

2003-10-01 to 2008-06-24 | Ph.D.
Education
Source: Self-asserted source
Javier Cotignola

Universidad de Buenos Aires: CABA, AR

1995-03-01 to 2001-03-01 | Biochemist
Education
Source: Self-asserted source
Javier Cotignola

Professional activities (3)

American Society of Clinical Oncology: Alexandria, US

2024 to present
Membership
Source: Self-asserted source
Javier Cotignola

Sociedad Argentina de Hematología: Buenos Aires, AR

2010 to present
Membership
Source: Self-asserted source
Javier Cotignola

Sociedad Argentina de Investigación Clínica: Buenos Aires, AR

2009 to present
Membership
Source: Self-asserted source
Javier Cotignola

Funding (5)

Characterization of exosomes and study of the molecular processes associated with bone and liver metastasis of prostate cancer

2023-01 to 2025-12 | Grant
University of Buenos Aires (Buenos Aires, AR)
Source: Self-asserted source
Javier Cotignola

Study of molecular biomarkers of relapse and acute drug-related toxicity in pediatric Acute Lymphoblastic Leukemia

2019 to 2022 | Grant
Agencia Nacional de Promoción Científica y Tecnológica (Buenos Aires, AR)
Source: Self-asserted source
Javier Cotignola

Study of molecular alterations involved in the development of castrate-resistant prostate cancer

2018 to 2021 | Grant
Agencia Nacional de Promoción Científica y Tecnológica (Buenos Aires, AR)
Source: Self-asserted source
Javier Cotignola

Study of molecular biomarkers of relapse and acute drug-related toxicity in pediatric Acute Lymphoblastic Leukemia

2017 to 2019 | Grant
Fundación para el Progreso de la Medicina (Córdoba, AR)
Source: Self-asserted source
Javier Cotignola

Pharmacogenetics protocol ALL IC-GATLA 2010: study of biomarkers for relapse and acute drug-related toxicity in pediatric Acute Lymphoblastic Leukemia

2016 to 2018 | Grant
National Cancer Institute (Buenos Aires, AR)
Source: Self-asserted source
Javier Cotignola

Peer review (3 reviews for 2 publications/grants)

Review activity for Cancers. (2)
Review activity for Communications biology. (1)
How many people are using ORCID?